I Peace
I Peace is a GMP cell therapy CDMO whose platform enables fully-automated mass production of discrete iPSCs.
- 18
- Private company
- Palo Alto, CA, USUnited States
I Peace is a GMP cell therapy CDMO whose platform enables fully-automated mass production of discrete iPSCs.
ipeace.comCrawled Oct 21, 2026
I Peace, Inc. obtained approval for manufacturing specific cell products and began offering clinical-grade iPSC production services.
Research teams led by Yu and Liu created a three-dimensional structure resembling human blastocysts from cultured cells, publishing their findings in *Nature*.
I Peace, Ltd. received certification for its privacy mark.
A Stanford University research team studied the antitumor effects of an iPSC-based cancer vaccine in pancreatic cancer.
University of Wisconsin–Madison researchers transplanted iPS cell-derived dopamine neuron precursor cells into Parkinson’s disease model monkeys, improving symptoms.
UCLA and Stanford researchers cultivated a human brain organoid for up to 20 months, observing maturation patterns similar to human brain development.
Kyoto University’s CiRA team successfully created iPS cells with reduced rejection risk using genome editing.
The homepage now features a new article introducing recent regenerative medicine research, including Kyoto University’s genome-edited iPS cells with reduced rejection risk.
The homepage now features a new article introducing recent regenerative medicine research, including a study on feeder-free T cell production from iPS cells.
Company overview of I Peace, including vision, mission, strengths, technology, location, and team member profiles.
I Peace’s Palo Alto quality control testing facility is ISO 17025:2017 accredited.
I Peace, Inc. provides GMP-compliant iPSC products, media, and custom cell manufacturing services globally, meeting PMDA and FDA standards.